Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Jul;9(1):49-53.
doi: 10.15420/ecr.2014.9.1.49.

Mitral Regurgitation - A Multidisciplinary Challenge

Eduardo Alegria-Barrero  1 , Olaf W Franzen  2
Affiliations
Review

Mitral Regurgitation - A Multidisciplinary Challenge

Eduardo Alegria-Barrero et al. Eur Cardiol. 2014 Jul.

Abstract

Mitral regurgitation is an increasing valvular disease that represents a difficult management challenge. Surgical treatment for degenerative mitral regurgitation is the standard of care treatment. Percutaneous therapies have emerged rapidly over the past years as an option for treatment of mitral regurgitation for selected, predominantly high-risk patients. Catheter-based devices mimic these surgical approaches with less procedural risk. Mitraclip® implantation mimics the surgical edge-to-edge leaflet repair technique, reducing the regurgitant area. We review the increasing evidence with the Mitraclip device reported to date.

Keywords: Mitral valve; degenerative mitral regurgitation; functional mitral regurgitation; mitraclip; mitral regurgitation; mitral valve surgery.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Olaf W Franzen is a consultant for Abbott Vascular. Eduardo Alegria-Barrero has no conflicts of interest to declare.

Figures

Figure 1:
Figure 1:. Carpentier’s Classification of Mitral Regurgitation
Figure 2:
Figure 2:. MitraClip® Delivery System and Guiding Catheter and Characteristics of the Clip
Figure 3:
Figure 3:. Three-dimensional Transoesophageal Echocardiogram Guidance During MitraClip® Implantation
See this image and copyright information in PMC

References

    1. Perlowski A, St Goar F, Glower DG, Feldman T. Percutanenous therapies for mitral regurgitation, Curr Probl Cardiol. 2012;37(2):42–68. - PubMed
    1. Feldman T, Young A. Percutaneous approaches to valve repair for mitral regurgitation, J Am Coll Cardiol. 2014;63(20):2057–68. - PubMed
    1. Franzen O, van der Heyden J, Baldus S MitraClip® therapy in patients with end-stage systolic heart failure, Eur J Heart Fail. 2011. 13. pp. 569–76. - PubMed
    1. Maisano F, Franzen O, Baldus S MitraClip therapy demonstrates favourable mid-term outcomes in ACCESS-EUROPE heart failure patients with left ventricular ejection fraction 30%: preliminary report from the 6-month ACCESS-EU analysis cohort, Eurointerv. 2011. 7.
    1. Ling LH, Enriquez-Sarano M, Seward JB et al. Clinical outcome of mitral regurgitation due to flail leaflet, N Engl J Med. 1996;335(19):1417–23. - PubMed